ArticleBiophysical journal2026
Protein function-conditioned language models for variant effect prediction and controllable design.
Article in Biophysical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Protein function-conditioned generative modeling can unify two core goals in protein engineering: predicting the effects of sequence variants and designing new sequences that satisfy functional constraints. We present a framework that conditions protein language modeling on molecular function semantics encoded from the Gene Ontology (GO) as a text-attributed directed acyclic graph. By embedding GO text and ontology topology, our function embedding captures relationships among functions and supports cross-function transfer. Function-conditioned meta-pretraining across diverse protein families further enables cross-family transfer before family-specific fine-tuning. Using these GO embeddings as conditioning context, we develop Func2Seq, a transformer-based autoregressive model of P(seq|func) that supports likelihood-based variant effect scoring and controllable sequence sampling. We further introduce Func2Prot, a joint sequence-structure extension that models P(seq, str|func) and enables direct backbone generation via a backbone-angle decoder. On a standard family-specific variant effect prediction benchmark, Func2Seq improves predictive performance over strong alignment-free and alignment-based baselines, and ablations show consistent gains from meta-pretraining when paired with family adaptation. A factor analysis indicates the largest improvements for small or low-diversity families. We also include enzyme fitness case studies to probe when joint sequence-structure modeling helps. For controllable design, we focus on the AT-rich interaction domain and show functional site-level constraint preservation while exploring globally novel sequence space, emphasizing function-critical binding regions and structural plausibility under appropriate evaluation pipelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.